IPF-Fibroblast Erk1/2 Activity Is Independent from microRNA Cluster 17-92 but Can Be Inhibited by Treprostinil through DUSP1
Idiopathic pulmonary fibrosis (IPF) is a progressive terminal lung disease, and therapies aim to block fibrosis. Fibroblast proliferation is controlled by C/EBP-β, microRNA cluster 17-92 (miR17-92), and Erk1/2 mitogen-activated protein kinase. This study assessed the role of miR17-92 in IPF-fibrobla...
Main Authors: | Sabrina Blumer, Lei Fang, Wei-Chih Chen, Petra Khan, Katrin Hostettler, Michael Tamm, Michael Roth, Christopher Lambers |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/11/2836 |
Similar Items
-
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
by: Luca Forte, et al.
Published: (2018-05-01) -
Revisiting the roles of VHR/DUSP3 phosphatase in human diseases
by: Lilian Cristina Russo, et al.
Published: (2018-09-01) -
Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway
by: Xue Liu, et al.
Published: (2021-01-01) -
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
by: Ping Wee, et al.
Published: (2017-05-01) -
DUSP-1 Induced by PGE<sub>2</sub> and PGE<sub>1</sub> Attenuates IL-1β-Activated MAPK Signaling, Leading to Suppression of NGF Expression in Human Intervertebral Disc Cells
by: Takuya Kusakabe, et al.
Published: (2021-12-01)